What is the effect of menopausal hormone replacement therapy on urinary incontinence?

Nature Clinical Practice Urology

Volumn 2, Issue 7, 2005, Pages 328-329

  Staskin, David R ^a   Tyagi, Renuka ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Estrogen; Hormone replacement therapy (HRT); Progestin; Urinary incontinence; Women's Health Initiative

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

BEHAVIOR MODIFICATION; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MENOPAUSAL SYNDROME; META ANALYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SHORT SURVEY; STRESS INCONTINENCE; SYMPTOM; SYSTEMATIC REVIEW; URGE INCONTINENCE; URINE INCONTINENCE;

EID: 23744459045     PISSN: 17434270     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpuro0248     Document Type: Short Survey

References (6)

1. Abrams P et al. (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61: 37-49
2. Grady D et al. (2001) Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 97: 116-120
3. Grodstein F et al. (2004) Postmenopausal hormone therapy and risk of developing urinary incontinence. Obstet Gynecol 103: 254-260
4. Goldstein SR et al. (2005) Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen. Menopause 12: 160-164
5. Cardozo L et al. (2004) A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand 83: 892-897
6. Smith PG and Bradshaw S (2004) Innervation of the proximal urethra of ovariectomized and estrogen-treated female rats. Histol Histopathol 19: 1109-1116